| abstract |
The present invention provides 2-cyanopyrimidin-4-yl carbamate or urea derivatives or pharmaceutically acceptable salts thereof, methods for preparing the same, and pharmaceutical compositions comprising the same. The 2-cyanopyrimidin-4-yl carbamate or urea derivatives or pharmaceutically acceptable salts thereof may be usefully applied for the prevention or treatment of osteoporosis by selectively inhibiting kadipsin K. |